NCT04705753View on ClinicalTrials.gov

Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

October 15, 2020

Study Completion Date

October 15, 2020

Conditions

Covid19Viral InfectionRespiratory Viral Infection

Interventions

DIETARY_SUPPLEMENT

Cretan IAMA

Cretan IAMA (CAPeo) soft gels, 1 ml/day of a 1.5% essential oil combination from three aromatic plants (Thymbra 59 capitata (L.) Cav., Origanum dictamnus L., Salvia fruticosa Mill.) in extra virgin olive oil

Trial Locations (1)

Unknown

Cretan Medicare, Heraklion